MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
137.88%
Quick Ratio
137.88%
Cash Ratio
46.12%
Debt to Asset Ratio
64.18%
Unit: Thousand (K) dollars
Assets Breakdown
    • Goodwill
    • Marketable securities
    • Less accumulated depreciation
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Contingent consideration
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
57,073
83,800
71,870
103,357
Marketable securities
103,417
17,336
66,512
49,697
Restricted cash
4,195
4,195
4,195
4,195
Prepaid expenses and other current assets
5,944
6,359
6,099
4,510
Total current assets
170,629
111,690
148,676
161,759
Property and equipment, at cost
84,546
82,819
81,661
83,774
Less accumulated depreciation
59,382
57,146
54,755
53,843
Property and equipment, net
25,164
25,673
26,906
29,931
Operating lease right-of-use assets
35,355
35,845
38,313
40,704
Intangible asset
59,195
59,195
59,195
59,195
Goodwill
140,627
140,627
140,627
140,627
Other non-current assets
552
563
3,173
3,216
Total assets
431,522
373,593
416,890
435,432
Accounts payable
1,359
2,123
1,669
1,858
Accrued compensation
8,842
7,584
13,240
11,296
Accrued expenses and other current liabilities
8,232
8,124
8,679
7,991
Operating lease liabilities
14,507
14,878
14,938
14,368
Contingent consideration
90,812
53,556
40,200
-
Total current liabilities
123,752
86,265
78,726
35,513
Operating lease liabilities, net of current portion
59,232
60,450
63,924
67,868
Contingent consideration, net of current portion
60,013
80,907
83,518
115,141
Success payment liabilities
24,477
16,926
19,238
13,726
Other non-current liabilities
9,480
9,805
10,600
7,876
Total liabilities
276,954
254,353
256,006
240,124
Common stock, 0.0001 par value 750,000 shares authorized 299,306 and 266,732 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
30
27
27
26
Additional paid-in capital
2,114,465
2,015,441
2,009,845
1,985,452
Accumulated other comprehensive income (loss)
-66
-2
28
21
Accumulated deficit
-1,959,861
-1,896,226
-1,849,016
-1,790,191
Total stockholders' equity
154,568
119,240
160,884
195,308
Total liabilities and stockholders' equity
431,522
373,593
416,890
435,432
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$103,417K (7271.13%↑ Y/Y)Cash and cashequivalents$57,073K (-19.92%↓ Y/Y)Prepaid expenses andother current assets$5,944K (5.52%↑ Y/Y)Restricted cash$4,195K (0.00%↑ Y/Y)Property and equipment,at cost$84,546K (-1.35%↓ Y/Y)Total current assets$170,629K (106.82%↑ Y/Y)Goodwill$140,627K (0.00%↑ Y/Y)Intangible asset$59,195K (0.00%↑ Y/Y)Operating leaseright-of-use assets$35,355K (-17.82%↓ Y/Y)Property and equipment,net$25,164K (-23.93%↓ Y/Y)Other non-currentassets$552K (-82.85%↓ Y/Y)Less accumulateddepreciation$59,382K (12.85%↑ Y/Y)Total assets$431,522K (19.32%↑ Y/Y)Total liabilities andstockholders' equity$431,522K (19.32%↑ Y/Y)Total liabilities$276,954K (15.84%↑ Y/Y)Total stockholders'equity$154,568K (26.12%↑ Y/Y)Accumulated deficit-$1,959,861K (-12.12%↓ Y/Y)Accumulated othercomprehensive income (loss)-$66K Total currentliabilities$123,752K (270.03%↑ Y/Y)Contingent consideration,net of current...$60,013K (-48.76%↓ Y/Y)Operating leaseliabilities, net of current...$59,232K (-17.34%↓ Y/Y)Success paymentliabilities$24,477K (184.25%↑ Y/Y)Other non-currentliabilities$9,480K (15.02%↑ Y/Y)Additional paid-in capital$2,114,465K (13.04%↑ Y/Y)Common stock, 0.0001par value 750,000...$30K (30.43%↑ Y/Y)Contingent consideration$90,812K (-22.47%↓ Y/Y)Operating leaseliabilities$14,507K (4.88%↑ Y/Y)Accrued compensation$8,842K (-6.05%↓ Y/Y)Accrued expenses andother current...$8,232K (3.80%↑ Y/Y)Accounts payable$1,359K (-40.13%↓ Y/Y)

Sana Biotechnology, Inc. (SANA)

Sana Biotechnology, Inc. (SANA)